Covered recipient · General Payments record
KATHERINE M MUELLER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2022–2023
$265.25
- Reported across 14 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $161.83 | 8 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $45.41 | 2 |
| Biogen, Inc. | $31.48 | 2 |
| ARGENX US, INC. | $25.17 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $21.86 | 1 |
| UCB, Inc. | $21.55 | 1 |
| Amgen Inc. | $16.36 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $16.36 | 03/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020378369 | CMS |
| ARGENX US, INC. | $25.17 | 01/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1060400777 | CMS |
| Biogen, Inc. | $14.92 | 01/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1012230315 | CMS |
| Biogen, Inc. | $16.56 | 08/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1012139931 | CMS |
| Novartis Pharmaceuticals Corporation | $21.86 | 02/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 992921533 | CMS |
| Teva Pharmaceuticals USA, Inc. | $23.18 | 01/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056936615 | CMS |
| Teva Pharmaceuticals USA, Inc. | $22.23 | 04/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056936677 | CMS |
| UCB, Inc. | $21.55 | 03/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1021594445 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023
- Source files
- Dataset page · Bulk file · PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.